NECTRANOX

This brand name is authorized in Nigeria.

Active ingredients

The drug NECTRANOX contains one active pharmaceutical ingredient (API):

1	Itraconazole UNII 304NUG5GF4 - ITRACONAZOLE
	Itraconazole is a triazole derivative that inhibits fungal 14α-demethylase, resulting in a depletion of ergosterol and disruption of membrane synthesis by fungi.
	Read more about Itraconazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-8255	Capsule	NECTRANOX CAPSULE CAP 100 mg 4X7CAPSULES	6 RNW-PP-292165 NECTRANOX CAPSULE ITRACONAZOLE 100MG ITRACONAZOLE BP 100MG (EXCIPIENTS: E.H.G Capsule size “0”Red T/CT BP, Dummy pallets BP) B4-8255 Drugs Imported Products 4X7CAPSULES Prescription Only Medicine (POM) 11/9/2022 NECTAR HEALTHCARE LTD, 16B,RESIDENTIAL ROAD,GBAGADA PHASE II 14141978 kingsley.okeke2@gmail.com GLOBELA PHARMA PVT. LTD., 357 358, G.I.D.C., SACHIN, SURAT - 394 230, GUJARAT, INDIA, India	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J02AC02	Itraconazole	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AC Triazole and tetrazole derivatives
Discover more medicines within J02AC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-8255